| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Product containing precisely ferric hexacyanoferrate-II 500 milligram/1 each conventional release oral capsule (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Calcium 500 mg and risedronate sodium 35 mg oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Product containing precisely colchicine 500 microgram and probenecid 500 milligram/1 each conventional release oral tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely everolimus 500 microgram/1 each conventional release oral tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely dutasteride 500 microgram and tamsulosin hydrochloride 400 microgram/1 each conventional release oral capsule (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| fingolimod 500 mikrogram, oral kapsel | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| flufenazinhydroklorid 500 mikrogram + nortriptylin 10 mg, tablett | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Codeine phosphate 30 mg and paracetamol 500 mg oral capsule | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| paracetamol + difenhydraminhydroklorid 500 mg/25 mg, tablett | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| paracetamol 500 mg + metoklopramid 5 mg, tablett | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Ethinylestradiol 35 microgram and norethisterone 500 microgram oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Product containing precisely caffeine 65 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Hydrocodone bitartrate 10 mg and paracetamol 500 mg oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Hydrochlorothiazide 30 mg and methyldopa 500 mg oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Glibenclamide 5 mg and metformin hydrochloride 500 mg oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 3 | 
| Dextropropoxyphene napsylate 100 mg and paracetamol 500 mg oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely colchicine 500 microgram and probenecid 500 milligram/1 each conventional release oral tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Codeine phosphate 12.8 mg and paracetamol 500 mg oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Codeine phosphate 15 mg and paracetamol 500 mg oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Product containing precisely paracetamol 500 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Product containing precisely hydrocodone bitartrate 2.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Hydrocodone bitartrate 5 mg and paracetamol 500 mg oral capsule | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 3 | 
| Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 1 mg oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Lovastatin 20 mg and nicotinic acid 500 mg oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Clarithromycin 500 mg prolonged-release oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Benzalkonium chloride 500 microgram oromucosal lozenge | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely paracetamol 500 milligram/1 each conventional release rectal suppository (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Metronidazole 500 mg rectal suppository | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Tiabendazole 500 mg chewable tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Procainamide hydrochloride 500 mg prolonged-release oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely naproxen 500 milligram/1 each conventional release rectal suppository (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely glyceryl trinitrate 500 microgram/1 each conventional release sublingual tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| naproxen (som naproxennatrium) 500 milligram, enterotablett | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely potassium chloride 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Sodium valproate 500 mg gastro-resistant oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely lanthanum (as lanthanum carbonate) 500 milligram/1 each conventional release chewable tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely mesalazine 500 milligram/1 each prolonged-release oral tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Sodium valproate 500 mg prolonged-release oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Mesalazine 500 mg rectal suppository | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Domiphen bromide 500 microgram and lidocaine hydrochloride 5 mg oromucosal lozenge | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Product containing precisely valproic acid 500 milligram/1 each gastro-resistant oral capsule (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely cefazolin (as cefazolin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely cefradine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Aciclovir (as aciclovir sodium) 500 mg powder for solution for injection vial | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Cefotaxime (as cefotaxime sodium) 500 mg powder for solution for injection vial | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| doripenem (som doripenemmonohydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Aztreonam 500 mg powder for solution for injection vial | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Amobarbital sodium 500 mg powder for solution for injection vial | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| abobotulinumtoxin A 500 enheter/injektionsflaska, frystorkat pulver till injicerbar lösning | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Product containing precisely diamorphine hydrochloride 500 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| azitromycin (som azitromycindihydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely ampicillin (as ampicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Deferoxamine mesilate 500 mg powder for solution for injection vial | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely clarithromycin 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| cyklofosfamid (som cyklofosfamidmonohydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Amifostine 500 mg powder for solution for injection vial | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| ceftazidim (som ceftazidimpentahydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Botulinum toxin type A 500 unit powder for solution for injection vial | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for injection vial | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely vancomycin (as vancomycin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely flucloxacillin (as flucloxacillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Product containing precisely sodium fusidate 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| cilastatin (som cilastatinnatrium) 500 milligram/injektionsflaska och imipenem (som imipenemmonohydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska, suspension | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| cilastatin (som cilastatinnatrium) 500 milligram/injektionsflaska och imipenem (som imipenemmonohydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska, suspension | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Ganciclovir (as ganciclovir sodium) 500 mg powder for solution for injection vial | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely vigabatrin 500 milligram/1 sachet powder for conventional release oral solution (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| meropenem (som meropenemtrihydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | har täljarvärde som visar styrka | False | 500 | Inferred relationship | Some | 2 | 
| Ferric ammonium citrate 16 mg/mL and folic acid 500 microgram/mL oral solution | har täljarvärde för koncentrationsstyrka | False | 500 | Inferred relationship | Some | 2 | 
| Product containing precisely oxybutynin hydrochloride 500 microgram/1 milliliter conventional release oral solution (clinical drug) | har täljarvärde för koncentrationsstyrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely diazepam 500 microgram/1 milliliter conventional release oral suspension (clinical drug) | har täljarvärde för koncentrationsstyrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely nitrazepam 500 microgram/1 milliliter conventional release oral suspension (clinical drug) | har täljarvärde för koncentrationsstyrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely folic acid 500 microgram/1 milliliter conventional release oral solution (clinical drug) | har täljarvärde för koncentrationsstyrka | False | 500 | Inferred relationship | Some | 1 | 
| Sodium fluoride 500 microgram/mL oromucosal solution | har täljarvärde för koncentrationsstyrka | False | 500 | Inferred relationship | Some | 1 | 
| Product containing precisely isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | har täljarvärde för koncentrationsstyrka | False | 500 | Inferred relationship | Some | 1 |